High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast Cancer.
Quintela-Fandino M, Bermejo B, Zamora E, Moreno F, García-Saenz JÁ, Pernas S, Martínez-Jañez N, Jiménez D, Adrover E, de Andrés R, Mourón S, Bueno MJ, Manso L, Viñas G, Alba E, Llombart-Cussac A, Cortés J, Tebar C, Roe DJ, Grant A, Watson A, Colomer R, Mouneimne G.
Quintela-Fandino M, et al. Among authors: grant a.
Clin Cancer Res. 2024 Nov 15;30(22):5094-5104. doi: 10.1158/1078-0432.CCR-24-1518.
Clin Cancer Res. 2024.
PMID: 39283720
Clinical Trial.